Forma Therapeutics Holdings Inc

NASDAQ:FMTX   2:30:36 PM EDT
19.95
+0.04 (+0.20%)
Other Pre-Announcement, Mergers / Acquisitions

Novo Nordisk To Acquire Forma

Published: 09/01/2022 12:44 GMT
Forma Therapeutics Holdings Inc (FMTX) - Novo Nordisk to Acquire Forma Therapeutics and Expand Presence in Sickle Cell Disease and Rare Blood Disorders.
Forma Therapeutics Holdings Inc - Novo Nordisk Will Acquire Forma Therapeutics for $20 per Share in Cash.
Forma Therapeutics Holdings Inc - Proposed Deal for Total Equity Value of $1.1 Billion.
Forma Therapeutics - Deal Will Not Impact Novo Nordisk's Previously Communicated Operating Profit Outlook for 2022 Or Ongoing Share Buy-back Program.
Forma Therapeutics Holdings Inc - Novo Nordisk Will Fund Acquisition From Financial Reserves.
Forma Therapeutics - Some Affiliates of Ra Capital Management, Which Collectively Own About 19% of Co's Shares, Have Entered Into Support Agreement.
Forma Therapeutics Holdings Inc - Upon Successful Completion of Tender Offer, Novo Nordisk's Acquisition Subsidiary Will Merge Into Forma Therapeutics.